Home › Meningioma › Nebraska › Omaha
Meningioma clinical trials in Omaha, NE
3 studies for Meningioma are looking for participants at sites in and around Omaha (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
RecruitingPhase 2
- Alegent Health Immanuel Medical Center, Omaha
- Alegent Health Bergan Mercy Medical Center, Omaha
- Alegent Health Lakeside Hospital, Omaha
Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
RecruitingObservational study
- University of Nebraska, Omaha
Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors
RecruitingPhase 1/2
- Nebraska Cancer Specialists, Omaha
Meningioma trials in other cities
- New York City, NY8 studies
- Miami, FL7 studies
- Boston, MA6 studies
- Columbus, OH6 studies
- San Francisco, CA5 studies
- San Diego, CA5 studies
- Atlanta, GA5 studies
- Jacksonville, FL5 studies
- Phoenix, AZ4 studies
- Arlington, VA4 studies
- Houston, TX4 studies
- Detroit, MI4 studies
Other studies in Omaha
- Prostate Cancer27 studies
- Non-Small Cell Lung Cancer24 studies
- Breast Cancer22 studies
- Colorectal Cancer18 studies
- Cancer (all types)18 studies
- Multiple Myeloma16 studies
- Non-Hodgkin Lymphoma14 studies
- Ovarian Cancer14 studies
- Pancreatic Cancer14 studies
- Head and Neck Squamous Cell Carcinoma13 studies
- Heart Failure13 studies
- Metastatic Cancer13 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.